Latest market headlines for GLENMARK on Terminal.
04-Nov-2026 19:39:57
• Updated Phase 1 TRIgnite-1 data for ISB 2001 (ABBV-2001) selected for oral presentation at the 68th ASH Annual Meeting on December 12, 2026 • ISB 2001 is an…
23-Sept-2026 08:42:13
• The company has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for its formulations manufacturing f…
11-Sept-2026 08:52:18
• Glenmark Specialty S.A., a wholly-owned subsidiary of Glenmark Pharmaceuticals, announced the launch of RYALTRIS® Nasal Spray in Brazil. • The product is for…
06-Jul-2026 08:38:38
• Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial. • The product is bioequivalent and therapeutically eq…
02-Jul-2026 08:37:12
• Glenmark Specialty S.A. announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811) for patients with platinu…
12-Jun-2026 19:06:12
Buy, TP raised to Rs 2750 Analyst day takeaways, GLEN is confident of driving 13-15% sales growth & 100bps margin improvement to FY30 led by Branded biz with I…